Background illustration for clinical trials search

Paid Clinical Trials Paterson

Discover 1,565 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Periprosthetic Fracture Registry (PPFx)

for
Periprosthetic Fractures,
Location: Livingston NJ, Jersey City NJ, Nashville TN,
Sponsor: AO Innovation Translation Center

Sex: All

Age: 18+

Code: NCT03378557

Recruiting

ATATcH Alternating Treatment Plans for Advanced Cancer

for
Head and Neck Cancer, Lung Cancer
Location: Livingston NJ, Newark NJ, Jersey City NJ, Elizabeth NJ,
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05358548

Phase2, Recruiting

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

for
Colon Cancer, Rectal Cancer
Location: Livingston NJ, Jersey City NJ, Elizabeth NJ,
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05806931

Phase2, Recruiting

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

for
Renal Transplant Failure and Rejection
Location: Livingston NJ, Ann Arbor MI, Atlanta GA, Tampa FL,
Sponsor: Nefro Avillion Clinical Development, LLC

Sex: All

Age: 18 - 70

Code: NCT07508787

Phase2, Recruiting

A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

for
Microvascular Inflammation
Location: West Orange NJ, Philadelphia PA, Richmond VA,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT07219043

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

for
Multiple Sclerosis (MS) Primary Progressive
Location: Livingston NJ, Raleigh NC, Columbus OH, Greenville SC,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07067463

Phase3, Recruiting

RADA16 for Adult Tonsillectomy

for
Postoperative Pain
Location: Livingston NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT07060495

Phase3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Livingston NJ, Jersey City NJ, New York NY, Flushing NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase2, Recruiting

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

for
Cytomegalovirus (CMV), Kidney Transplant; Complications,
Location: Livingston NJ, Richmond VA, Atlanta GA, Miami FL,
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06798909

Phase3, Recruiting

Stress Hydrocortisone In Pediatric Septic Shock

for
Septic Shock
Location: Livingston NJ, Wilmington DE, Hershey PA, Boston MA,
Sponsor: Jerry Zimmerman

Sex: All

Age: 0 - 17

Code: NCT03401398

Phase3, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Livingston NJ, New York NY, The Bronx NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Livingston NJ, New York NY, Sleepy Hollow NY,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for
Classic Follicular Lymphoma,
Location: Livingston NJ, New Brunswick NJ, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06337318

Phase3, Recruiting

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Livingston NJ, New Brunswick NJ, Toms River NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04628767

Phase2, Phase3, Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

for
Cataract, Presbyopia, Posterior Capsule Opacification
Location: South Orange NJ, Dover NJ, Bala-Cynwyd PA,
Sponsor: Bausch & Lomb Incorporated

Sex: All

Age: 22+

Code: NCT06060041

Recruiting

Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder

for
Cannabis Withdrawal
Location: New York NY, Staten Island NY, New Haven CT, Marlton NJ,
Sponsor: PleoPharma, Inc.

Sex: All

Age: 18 - 55

Code: NCT07644052

Phase3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: New York NY, The Bronx NY, Mineola NY, New Brunswick NJ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

for
Prostatic Neoplasms
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT06095089

Phase1, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: New York NY, The Bronx NY, Summit NJ, Morristown NJ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: New York NY, New Brunswick NJ, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase1, Phase2, Recruiting